Sponsor:
Jade Biosciences, Inc.
Code:
NCT07525947
Conditions
Healthy Volunteers (HV)
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Interventions
JADE101
Brief summary:
Conditions
Healthy Volunteers (HV)
Study ID
NCT07525947
Start date
May 1, 2026
Status verified date
Jun, 2026
Completion date
May, 2027
Anticipated
Primary completion date
May, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 18 - 55
Healthy Volunteers: Accepted
Enrollment
40 participants
Anticipated
Allocation
Non randomized
Intervention Model
Sequential
Primary purpose
Basic Science
Arms
experimental: JADE101 Groups 1 and 2
experimental: JADE101 Groups 3 and 4
Interventions
JADE101
Primary outcome measure
Central contacts
Locations
Parexel Early Phase Clinical Unit (EPCU)
Recruiting
Glendale, California, United States, 91206
Contacts
Sponsor
Jade Biosciences, Inc.
Last update posted
Jun 4, 2026
Last verified
Jun, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Jade Biosciences, Inc. on 2026-06-04.